Transactions: Sweden
Filter
Acquisition of Attendo AB (SE) by Bridgepoint (UK) — SEK 2.2 billion
Public offer for Biacore International (SE) by GE Healthcare (US) — SEK 3.2 billion
Block trade of shares in Swedish Orphan Biovitrum (SE) — SEK 231 million
Initial public offering of Castellum (SE) — SEK 1.8 billion
Secondary placing of 10.85 million shares in NCC (SE) — SEK 1.2 billion
Divestment of Infratek ASA (NO) to Triton (SE) by Hafslund ASA (NO) and Fortum Nordic AB (SE) — NOK 0.9 billion
Secondary placing of 5.1 million shares in Intrum Justitia (SE) — SEK 343 million
Secondary placing of shares in Q-Med AB (SE) — SEK 128 million
Rights issue in Karo Bio (SE) — SEK 125 million
Secondary placement of shares in Karo Bio (SE) — SEK 96 million